Injected Xolair Therapy Could Prevent Food Allergies in Kids
THURSDAY, Dec. 21, 2023 (HealthDay News) — A new treatment appears to reduce food allergies in children and teens, according to interim clinical trial results. A lab-made monoclonal antibody called omalizumab (Xolair) significantly increased the amounts of common foods that children could eat without sparking an allergic reaction, the U.S.Continue Reading